0001127602-24-016813.txt : 20240529 0001127602-24-016813.hdr.sgml : 20240529 20240529174226 ACCESSION NUMBER: 0001127602-24-016813 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240528 FILED AS OF DATE: 20240529 DATE AS OF CHANGE: 20240529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Llorens Josep CENTRAL INDEX KEY: 0001750812 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 24999902 MAIL ADDRESS: STREET 1: HAEMONETICS CORPORATION STREET 2: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0330 BUSINESS ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-05-28 0000313143 HAEMONETICS CORP HAE 0001750812 Llorens Josep 125 SUMMER STREET BOSTON MA 02110 1 EVP, Global Manufacturing 0 Common Stock 2024-05-28 4 A 0 14140 0 A 35450 D Common Stock 2024-05-28 4 F 0 4510 95.73 D 30940 D Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on May 18, 2021, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from May 18, 2021 to May 17, 2024, as certified by the Compensation Committee of the Board of Directors on May 26, 2024. This number includes unvested restricted stock units ("RSUs") previously reported. Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I. /s/ Thomas V. Powers, attorney-in-fact for Mr. Llorens 2024-05-29